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Abstract Glomerular mesangial cells are regarded as specia- 
lized smooth muscle cells located within the renal glomeruli and 
fulfilling important functions in glomerular physiology and 
pathophysiology. Here, we report that activation of the cyclic 
AMP signalling pathway by dibutyryl cyclic AMP, forskolin, or 
the ~2-adrenergic receptor agonist salbutamol results in induction 
of apoptosis in mesangial cells. Activation of the apoptotic 
programme results in DNA fragmentation which is visible for 
most forms of apoptosis and is paralleled by enrichment of 
cytosolic DNA/histone complexes, an increasing number of 
cellular 3'-OH-fragmented DNA ends and typical nuclear 
chromatin condensation. Induction of apoptosis was found to 
be dependent on translation and independent of nitric oxide 
synthase activity. 
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characterize cellular signals which initiate the apoptotic pro- 
gramme in mesangial cells. Here we present evidence that 
activation of the cyclic AMP signalling pathway results in 
mesangial cell apoptosis in a translation-dependent a d nitric 
oxide synthase-independent manner. 
2. Materials and methods 
2.1. Chemicals 
Salbutamol was generously supplied by Dr. Irmgard Wiesenberg, 
Ciba-Geigy Ltd., Basel, Switzerland; forskolin was from Calbiochem 
(Lucerne, Switzerland); NG-monomethyl-L-arginine (L-NMMA) was 
from Alexis (L~iufelfingen, Switzerland). Cell death detection ELISA 
and in situ cell death detection kit were from Boehringer Mannheim 
(Rotkreuz, Switzerland). Cell culture media and nutrients were ob- 
tained from Gibco BRL (Basel, Switzerland) and all other chemicals 
were either from Merck (Darmstadt, Germany), Fluka (Buchs, Swit- 
zerland) or Sigma (Buchs, Switzerland). 
1. Introduction 
Apoptosis is a controlled biological strategy to remove un- 
wanted cells from a given tissue and thus is involved in phys- 
iological and pathophysiological processes, e.g. limb forma- 
tion during development, removal of self-reactant or 
hyperactivated immune cells as well as of virus-infected and 
tumour cells. Apoptosis is characterized by an ordered se- 
quence of cellular events which include cellular shrinking, nu- 
clear condensation, and disintegration of the dying cell into 
apoptotic bodies which are rapidly taken up by neighbouring 
cells. Thus the leakage of cell constituents with secondary 
inflammation is prevented. In most cellular systems apoptosis 
is associated with the activation of  endonucleases which cleave 
double stranded DNA at the internucleosomal linker region 
thereby producing mono- and polynucleosomal DNA frag- 
ments. These fragments give rise to the typical DNA ladder 
which consists of  multiples of  about 180 bp units, regarded a 
biochemical marker of  apoptotic ell death [1,2]. 
Mesangial cells located within the renal glomerulus are re- 
garded as specialized smooth muscle cells, involved in the 
regulation of the glomerular filtration rate [3]. Moreover, 
once activated in a proinflammatory context mesangial cells 
release a variety of proinflammatory mediators and growth 
factors, thus being an important determinant of the immuno- 
logical status of the renal glomerulus and contributing to 
glomerular pathophysiology [4]. Since apoptosis of mesangial 
cells was detected uring the course of experimentally induced 
glomerulonephritis [5] this study was undertaken to further 
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2.2. Cell culture 
Rat mesangial cells were cultured, cloned and characterized as de- 
scribed previously [6]. The cells were grown in RPMI 1640 supple- 
mented with 10% fetal calf serum, penicillin (100 units/ml), strepto- 
mycin (100 /ag/ml) and bovine insulin (0.66 units/ml). For the 
experiments passages 10-18 of mesangial cells were used. 
2.3. Analysis of DNA fragmentation byDNA agarose gel 
eleetrophoresis 
Confluent mesangial cells in 85 mm diameter dishes were washed 
twice with PBS and incubated in DMEM without phenol red contain- 
ing 0.1 mg of the fatty acid free BSA/ml with the indicated concen- 
trations of compounds. Thereafter cells were lysed in lysis buffer (50 
mM Tris/HC1 pH 7.5, 20 mM EDTA, 1% NP-40) and apoptotic DNA 
fragments were isolated [7]. Electrophoresis was performed in a 1.5% 
agarose gel and DNA was stained using ethidium bromide (1 pg/ml). 
Photographs were taken by UV transillumination. 
2.4. Cell death detection by analysis of cytosolic oligonucleosome-bound 
DNA 
Confluent mesangial cells in 35 mm diameter dishes were washed 
twice with PBS and incubated in DMEM. Cytosolic oligonucleosome- 
bound DNA was quantitated using an ELISA kit with a primary anti- 
historic antibody and a secondary anti-DNA antibody coupled to 
peroxidase according to the manufacturer's instruction. Absorbance 
values (A,105nra/4S6nrn) are a relative measure for DNA fragmentation. 
Percentage of fragmentation is expressed in comparison to controls 
[8]. 
2.5. In situ detection of apoptosis 
Cells grown on glass plates were treated with different agents, 
washed with PBS, and fixed with 4% formaldehyde-containing PBS. 
Mesangial cells were blocked for 15 min with 0.3% H202 in methanol, 
washed and permeabilized for 2 rain on ice with 0.1% sodium citrate 
in PBS. Apoptotic cells were detected in situ by enzymatically abel- 
ling the free 3'-OH DNA terminus using an in situ cell death detection 
kit. The reaction mixture was added for 60 rain at 37°C. Following 
further washing the glass plates were incubated for 30 rain at 37°C 
with anti-fluorescine antibody coupled to peroxidase. As chromomere 
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0.05% diaminobenzidine i  1% nickel sulfate and 0.01% H202 was 
added for 15 rain. Stained cells were dehydrated with increasing 
amounts of alcohol, dipped in xylol, and coverslips were sealed with 
Eukitt and evaluated by interference microscopy [9]. 
2.6. Staining of nuclei with Hoe-33258 
Confluent mesangial cells in 35 mm diameter dishes were washed 
twice with PBS and incubated in DMEM with the indicated concen- 
trations of compounds. Thereafter the cells were fixed in 3% para- 
formaldehyde in phosphate buffer (100 mM, pH 7.4). From a stock 
solution Hoe-33258 (1mg/ml) was added up to a final concentration 
of 30 ~tg/ml. The nuclei were viewed under a fluorescence microscope 
using standard excitation filters [10]. 
3. Results 
Analysis of DNA by gel electrophoresis reveals internucleo- 
somal DNA fragmentation i mesangial cells exposed to 
either dibutyryl cyclic AMP (Fig. la), forskolin (Fig, lb) or 
salbutamol (Fig. lc), which all increase intracellular cyclic 
AMP levels either directly, by immediate activation of the 
catalytic subunit of the adenylyl cyclase, or by a [32-adrenergic 
receptor coupled mechanism. Characteristic apoptotic DNA 
fragmentation was almost undetectable in unstimulated con- 
trol cells. The forskolin analogue 1,9-dideoxyforskolin, which 
is inactive as a stimulator of adenylyl cyclase, has no effect on 
DNA fragmentation. I duction of DNA laddering was found 
to be dependent on protein synthesis ince incubation of the 
cells with forskolin in combination with cycloheximide effi- 
ciently blocked DNA fragmentation (Fig. lc). We have re- 
cently shown that cyclic AMP induces the expression of nitric 
oxide synthase in mesangial cells [11,12]. Furthermore, we 
have observed induction of apoptosis in mesangial cells ex- 
posed to exogenous nitric oxide donors (H. Mt~hl, K. Sandau, 
B. Brtine, J. Pfeilschifter, unpublished observations). There- 
fore we investigated next whether activation of apoptotic 
DNA degradation by the cyclic AMP signalling pathway is 
dependent on induction of nitric oxide synthase activity in 
mesangial cells. Cells exposed to forskolin release small but 
significant amounts of nitric oxide [11]. However, blockage of 
nitric oxide synthase activity by L-NMMA did not inhibit 
forskolin induced DNA fragmentation i dicating that nitric 
oxide is not required for cyclic AMP-induced apoptosis (Fig. 
2). DNA fragmentation was paralleled by enrichment of cy- 
tosolic DNA/histone complexes in response to elevated levels 
of cyclic AMP (Table 1). Again cycloheximide efficiently an- 
tagonized apoptosis indicating translational dependence (Ta- 
ble 1). To further extend these results to the level of the single 
cell we performed in situ detection of apoptosis by labelling 
the cellular free 3'-OH DNA ends using terminal deoxynu- 
cleotidyl transferase (TUNEL staining). Exposure of mesan- 
gial cells to forskolin results in a massive increase of TUNEL 
positive cells which further confirms cyclic AMP- dependent 
apoptotic DNA degradation (Fig. 3). Chromatin condensa- 
tion which may occur independent of DNA fragmentation 
[13] is another characteristic feature of ongoing apoptosis. 
Nuclear staining of mesangial cells treated with forskolin re- 
vealed typical apoptotic chromatin condensation (Fig. 4) 
which often co-localized with budding at the cell membrane, 
visible by light microscopy. After a 24 h incubation with for- 
skolin (20 p,M) approximately 10% of the cells exhibited con- 
densed chromatin which is not detectable in untreated mesan- 
gial cells (Fig. 4). 
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Fig. 1. (a) DNA fragmentation i  mesangial cells induced by dibu- 
tyryl cyclic AMP. Cells were incubated for 24 h with dibutyryl cyc- 
lic AMP 5 mM (lane 1), 1 mM (lane 2) or vehicle (lane 3); lane 4 
displays DNA markers. (b) DNA fragmentation i  mesangial cells 
induced by forskolin. Cells were incubated for 24 h with forskolin 
30 ~tM (lane 1), 10 ].tM (lane 2) or vehicle (control, lane 3); lane 4 
displays DNA markers. (c) Induction of DNA fragmentation bysal- 
butamol and inhibition of forskolin induced DNA fragmentation by
cycloheximide. Mesangial cells were incubated for 24 h with vehicle 
(control, lane 1), forskolin 15 I.tM (lane 2), forskolin 15 ~tM plus cy- 
cloheximide 10 ].tM (lane 3) or with salbutamol 25 i.tM (lane 4). 
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Fig. 2. Cyclic AMP induction of DNA fragmentation i  mesangial 
cells is not mediated by nitric oxide. Mesangial cells were incubated 
for 24 h with forskolin 10 I.tM (lane 1), vehicle (control, lane 2), 
forskolin 10 ktM plus L-NMMA 1 mM (lane 3) and with forskolin 
10 pM plus L-NMMA 2 mM (lane 4). 
4. Discussion 
Elevated levels of intracellular cyclic AMP are known to 
induce apoptotic cell death in rat leukemia cell lines [14], in 
rat primary granulosa cells [15], in rat thymocytes [16] and in 
human B lymphocytes [17]. Here we extend these reports, 
substantiating that rat renal mesangial cells are susceptible 
to cyclic AMP-induced apoptosis. 
The cellular cyclic AMP signalling pathway was activated 
by different means: (i) a receptor-coupled mechanism using 
the 132-adrenergic receptor agonist salbutamol, (ii) direct stim- 
ulation of the catalytic subunit of adenylyl cyclase with for- 
skolin or (iii) exposure of the cells to a membrane-permeant 
cyclic AMP analogue, dibutyryl cyclic AMP. Activation of the 
apoptotic programme was verified on a biochemical basis by 
detection of apoptotic DNA degradation (Fig. 1Fig. 2Fig. 3) 
and on the basis of morphology by demonstrating typical 
nuclear chromatin condensation i cyclic AMP-activated me- 
sangial cells (Fig. 4). Cyclic AMP-dependent induction of 
apoptosis was found to be dependent on protein synthesis 
and independent of induction of nitric oxide production 
(Fig. lc, Fig. 2). Whereas chromatin condensation was unde- 
tectable in control cells, approximately 10% of the cyclic 
AMP-activated mesangial cells showed an apoptotic morphol- 
Fig. 3. In situ detection of cyclic AMP-mediated apoptosis in me- 
sangial cells by TUNEL staining. Mesangial cells were incubated for 
24 h (a) with vehicle (control) and (b) with forskolin (10 p.M). 
Thereafter in situ detection of apoptotic ells by TUNEL staining 
was performed as described in section 2.5+ 
ogy. We propose that only a small proportion of the whole 
cell population is susceptible to cyclic AMP-induced apoptosis 
at a certain time point. However, since mesangial cells have a 
prominent phagocytic apacity [3] the overall degree of apop- 
totic cell death may be underestimated because apoptotic ells 
are likely to be phagocytosed rapidly by their neighbours. The 
molecular mechanism of cyclic AMP-induced apoptosis is not 
known, but the intracellular transduction mechanism is be- 
lieved to be exclusively protein kinase A mediated [18]. A 
fine-tuned crosstalk between the cyclic AMP/protein kinase 
A cascade and the mitogen-activated protein kinase family 
members has recently been suggested to control such funda- 
mental processes as cell proliferation (for review see [19]) and 
apoptosis [20]. Two principal response patterns to cyclic AMP 
Table 1 
Effects of cyclic AMP on cytosolic oligonucleosome-bound DNA in mesangial cells 
Addition DNA fragmentation 
Control 
Salbutamol (25 p.M) 
Dibutyryl cyclic AMP (5 raM) 
Forskolin (15 ~tM) 
Forskolin (15 I.tM) + cycloheximide (10 p_M) 
Cycloheximide (10 ktM) 
100 + 54.5 
398 + 18.9" 
640.2 + 79.6* 
1009.3 + 180'* 
335.9_+33.1 ++ 
174.3 _+ 88.5 
Mesangial cells were incubated with vehicle (control) or the indicated compounds for 24 h. Cytosolic oligonucleosome-bound DNA was quan- 
tiated by an ELISA kit, DNA fragmentation is indicated as % of untreated control cells. Data are means + S.D. of three independent experi- 
ments. Significant differences from control: **P < 0.01; *P < 0.05 (ANOVA). Significant difference from corresponding stimulation with forsko- 
lin alone: ++P < 0.01 (ANOVA). 
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Fig. 4. Detection of cyclic AMP-induced nuclear chromatin condensation i  mesangial cells. Mesangial cells were incubated for 24 h (a) with 
vehicle (control) and (b) with forskolin (20 gM). Thereafter the nuclei were stained with Hoe-33258 in order to detect chromatin condensation. 
have been described. Depending on the cell type cyclic AMP 
either inhibits or activates extracellular signal regulated ki- 
nases and thus either blocks or stimulates cell proliferation 
by a mechanism which involves protein kinase A-mediated 
Raf-1 kinase phosphorylation [19]. In a complementary fash- 
ion cAMP has been reported to modulate apoptosis in either a 
positive [14-16] or negative way [20,21] by modulating the 
dynamic balance between two members of the mitogen-acti- 
vated protein kinase family [20]. Importantly, cAMP has been 
shown to inhibit [3H]thymidine incorporation into growth 
factor-activated mesangial cells [22] and attenuates extracel- 
luar signal regulated kinases in response to angiotensin II or 
platelet-derived growth factor [19]. It is tempting to speculate 
that cAMP triggers an apoptotic signal in mesangial cells by 
unbalancing the opposing effects of specific members of mito- 
gen-activated protein kinase modules in a way complementary 
to that observed in PC-12 cells [20]. Several mediators are 
known to act on glomerular mesangial cells by stimulating 
the cyclic AMP signalling pathway. Examples are histamine, 
adenosine, prostaglandin E2, dopamine and others (for review 
see [3]). Recently Baker et al. [5] reported that mesangial cell 
apoptosis is induced during the course of Thy-1 nephritis in 
rats. In the pathogenesis of glomerular inflammatory diseases 
matrix production by mesangial cells and glomerular hyper- 
cellularity are supposed to be key steps in the progression 
towards sclerosis and loss of kidney function. We suggest 
that activation of the cyclic AMP signalling pathway during 
the course of glomerular inflammatory diseases may result in 
two beneficial effects complementing each other in counter- 
acting glomerular hypercellularity: the inhibition of mesangial 
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cell proliferation and the simultaneous induction of apoptosis 
of surplus mesangial cells. This may guarantee a sophisticated 
orderly process of repair. 
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